Altered prostanoid production by fibroblasts cultured from the lungs of human subjects with idiopathic pulmonary fibrosis

Respiratory Research

Volumn 3, Issue , 2002, Pages

  Cruz Gervis, Roberto ^a,b   Stecenko, Arlene A ^a   Dworski, Ryszard ^a   Lane, Kirk B ^a   Loyd, James E ^a   Pierson, Richard ^a   King, Gayle ^a   Brigham, Kenneth L ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Lung fibroblasts; Prostacyclin; Prostaglandins; Pulmonary fibrosis; Thromboxane

Indexed keywords

CYCLOOXYGENASE 2; ICOSANOID; INTERLEUKIN 1BETA; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTAGLANDIN F1 ALPHA; PROSTANOID; THROMBOXANE A2; THROMBOXANE B2; 6 OXOPROSTAGLANDIN F1 ALPHA;

ARTICLE; CELL FUNCTION; CELL STIMULATION; CLINICAL ARTICLE; ENZYME ANALYSIS; FEMALE; FIBROBLAST CULTURE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IDIOPATHIC DISEASE; LIPOGENESIS; LUNG FIBROSIS; MALE; NORTHERN BLOTTING; PATHOGENESIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UPREGULATION; WESTERN BLOTTING; ADULT; AGED; CONTROLLED STUDY; COX 2 GENE; ENZYME ACTIVITY; ENZYME INDUCTION; FATTY ACID SYNTHESIS; FIBROBLAST; FIBROSING ALVEOLITIS; GENE EXPRESSION REGULATION;

EID: 7244241100     PISSN: 1465993X     EISSN: None     Source Type: Journal    
DOI: 10.1186/rr166     Document Type: Article

References (28)

1. Gauldie J, Jordana M, Cox G: Cytokines and pulmonary fibrosis. Thorax 1993, 48:931-935
2. Tremblay GM, Jordana M, Gauldie J, Sarnstrand B: Fibroblasts as effector cells in fibrosis. In Pulmonary Fibrosis; Lung Biology in Health and Disease, 1995, 80:541-577
3. Crystal RG, Ferrans VJ, Basset F: Biologic basis of pulmonary fibrosis. In The Lung: Scientific Foundations. 1991 2031-2046
4. Strieter RM, Keane MP, Standiford TJ, Kunkel SL: Cytokine biology and the pathogenesis of interstitial lung disease. In Interstitial Lung Disease. 1998 181-205
5. Elias J: Tumor necrosis factor interacts with interleukin-1 and interferons to inhibit fibroblast proliferation via prostagland-independent and independent mechanisms. Am Rev Respir Dis 1988, 131:94-99
6. Goldstein R, Polgar P: The effect and interaction of bradykinin and prostaglandins on protein and collagen production by lung fibroblasts. J Biol Chem 1982, 257:8630-8633
7. Korn J, Halushka P, Leroy E: Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production. J Clin Invest 1980, 65:543-554
8. Baum B, Moss S, Breul R, Crystal R: Effect of cyclic AMP on the intracellular degradation of newly synthesized collagen. J Biol Chem 1980, 255:2843-2847
9. Baud L, Perez J, Denis M, Ardaillou R: Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin. J Immunol 1987, 138: 1190-1195
10. 2 enhances interleukin 8 (IL-8) and IL-6 but inhibits GMCSF production by IL-1 stimulated human synovial fibroblasts in vitro. J Rheumatol 1996, 23:862-868
11. 2 in a murine model of inflammation: possible role of cyclooxygenase-2. Proc Natl Acad Sci USA 1996, 93:4885-4890
12. 2 and to express cyclooxygenase-2. J Clin Invest 1995, 95:1861-1868
13. 1α on cultured fibroblasts. Biochim Biophys Acta 1977, 479:122-125
14. 2 and prostacyclin. Kidney Int 1990, 38:232-239
15. 2 in mitogenesis of vascular smooth muscle cells. Agents Actions 1997, 48:43-61
16. 2, and specific receptor antagonists on vascular smooth cell proliferation. Circulation 1997, 96:2280-2286
17. Sinzinger H, Fitscha P, Kritz H: Antimitotic actions of vasodilatory prostaglandins-clinical aspects. Agents Actions 1997, 48:93-106
18. Gallagher AM, Yu H, Printz MP: Bradykinin-induced reductions in collagen gene expression involve prostacyclin. Hypertension 1998, 32:84-88
19. Funk CD: Molecular biology in the eicosanoid field. Progress Nucleic Acid Res and Mol Biol 1993, 45:67-98
20. 2 production in normal and fibrotic lung fibroblasts: potential implications for the evolution of the inflammatory process. Am J Respir Cell Mol Biol 2000, 22:628-634
21. Keerthisingam CB, Jenkins RG, Harrison NK, Hernandez-Rodriguez NA, Booth H, Laurent GJ, Hart SL, Foster ML, McAnulty RJ: Cyclooxygenase-2 deficiency results in a loss of the antiproliferative response to transforming growth factor-β in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 2001, 158:1411-1422
22. Kumar RK, Bennett RA, Brody AR: A homologue of platelet-derived growth factor produced by rat alveolar macrophages. FASEB J 1988, 2:2272-2277
23. Dworski R, Sheller JR, Wickersham NE, Oates JA, Brigham KL, Roberts LJ II, Fitzgerald GA: Allergen-stimulated release of mediators into sheep bronchoalveolar lavage fluid; effect of cyclooxygenase inhibition. Am Rev Respir Dis 1989, 139:46-51
24. Fitzsimmons C, Proudfoot D, Bowyer DE: Monocyte prostaglandins inhibit procollagen secretion by human vascular smooth muscle cells: implications for plaque stability. Atherosclerosis 1999, 142:287-293
25. 2 and involves upregulation of thromboxane receptor mRNA. Circulation 1998, 97:589-595
26. 2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen. Eur J Pharmacol 1997, 319:327-332
27. Polgar P, Taylor L: Alterations in prostaglandin synthesis during senescence of human lung fibroblasts. Mech Ageing Dev 1980, 12:305-310
28. 2 and change in cyclic AMP production in response to prostacyclin in human diploid fibroblasts. Adv Prostaglandin Thromboxane Leukot Res 1983, 12:319-325